Afficher la notice abrégée

dc.contributor.authorJiménez Candil, Francisco Javier 
dc.contributor.authorHernández, Jesús
dc.contributor.authorMartín, Ana
dc.contributor.authorMoriñigo Muñoz, José Luis 
dc.contributor.authorLópez, Rosana
dc.contributor.authorLedesma, Claudio
dc.contributor.authorMartín Luengo, Cándido
dc.date.accessioned2024-12-16T09:54:40Z
dc.date.available2024-12-16T09:54:40Z
dc.date.issued2013-02
dc.identifier.citationJiménez-Candil, J., Hernández, J., Martín, A., Moríñigo, J., López, R., Ledesma, C., & Martín-Luengo, C. (2013). Influence of cycle length variations on antitachycardia pacing effectiveness among ICD patients. Heart Rhythm, 10(2), 207-213. https://doi.org/10.1016/J.HRTHM.2012.10.028es_ES
dc.identifier.issn1547-5271
dc.identifier.urihttp://hdl.handle.net/10366/161177
dc.description.abstract[EN]Antitachycardia pacing (ATP) fails to terminate 5% to 25% of ventricular tachycardias (VTs) occurring in implantable cardioverter-defibrillator patients. We speculated that small fluctuations in VT cycle length (CL) may be related to the efficacy of subsequent ATP. The purpose of this study was to determine the relationship between the R-R variations of the last 12 R-R intervals before ATP and the efficacy of the first ATP attempt. We studied 551 VTs (CL 329±35 ms) occurring in 67 patients. We also analyzed the percentage of variation (P-RR), which was calculated by dividing the mean difference between each R-R interval and the next one by the CL (×100), and the acceleration index (AI), which was calculated by dividing the CL of the first 6 R-R intervals by the CL of the next 6. The effectiveness of the first ATP therapy was 81%, being higher in VTs with AI<1 (85% vs 64%; P<.001). After classifying the events according to the tertiles of P-RR, ATP efficiency was better in higher values of P-RR (VTs with AI<1): 99% (third tertile) vs 85% (second tertile) vs 76% (first tertile), P<.001; and for VTs with AI≥1: 94% vs 68% vs 42% (P<.001). By logistic regression, P-RR (%; odds ratio 2.37; P<.001), and AI<1 (odds ratio 4.17; P<.001) were found to be independent predictors of successful first ATP attempts. Small changes in CL increase the effectiveness of ATP significantly. VTs with lower degrees of R-R fluctuations, especially when the pattern is a progressive CL shortening, are infrequently terminated by ATP.es_ES
dc.language.isoenges_ES
dc.publisherElsevieres_ES
dc.rightsAtribución/Reconocimiento-NoComercial-SinDerivados 4.0 Internacional*
dc.rights.urihttps://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.subjectAntitachycardiapacinges_ES
dc.subjectImplantablecardioverter- defibrillatores_ES
dc.subjectVentriculartachycardiaes_ES
dc.subject.meshAged *
dc.subject.meshAdult *
dc.subject.meshRisk Assessment *
dc.subject.meshFollow-Up Studies *
dc.subject.meshHumans *
dc.subject.meshDefibrillators *
dc.subject.meshElectrocardiography *
dc.subject.meshCombined Modality Therapy *
dc.subject.meshMiddle Aged *
dc.subject.meshMultivariate Analysis *
dc.subject.meshSeverity of Illness Index *
dc.subject.meshTreatment Outcome *
dc.subject.meshCohort Studies *
dc.subject.meshSurvival Rate *
dc.subject.meshTachycardia *
dc.subject.meshLogistic Models *
dc.subject.meshRetrospective Studies *
dc.titleInfluence of cycle length variations on antitachycardia pacing effectiveness among ICD patientses_ES
dc.typeinfo:eu-repo/semantics/articlees_ES
dc.relation.publishversionhttps://doi.org/10.1016/j.hrthm.2012.10.028
dc.identifier.doi10.1016/j.hrthm.2012.10.028
dc.rights.accessRightsinfo:eu-repo/semantics/embargoedAccesses_ES
dc.identifier.pmid23085131
dc.identifier.essn1556-3871
dc.journal.titleHeart Rhythmes_ES
dc.volume.number10es_ES
dc.issue.number2es_ES
dc.page.initial207es_ES
dc.page.final2013es_ES
dc.type.hasVersioninfo:eu-repo/semantics/draftes_ES
dc.subject.decshumanos *
dc.subject.decsíndice de gravedad de la enfermedad *
dc.subject.decsanciano *
dc.subject.decsestudios de seguimiento *
dc.subject.decsmodelos logísticos *
dc.subject.decsmediana edad *
dc.subject.decsanálisis multifactorial *
dc.subject.decsestudios retrospectivos *
dc.subject.decstratamiento combinado *
dc.subject.decstasa de supervivencia *
dc.subject.decsadulto *
dc.subject.decsdesfibriladores *
dc.subject.decsresultado del tratamiento *
dc.subject.decsevaluación de riesgos *
dc.subject.decsestudios de cohortes *
dc.subject.decselectrocardiografía *
dc.subject.decstaquicardia *


Fichier(s) constituant ce document

Thumbnail

Ce document figure dans la(les) collection(s) suivante(s)

Afficher la notice abrégée

Atribución/Reconocimiento-NoComercial-SinDerivados 4.0 Internacional
Excepté là où spécifié autrement, la license de ce document est décrite en tant que Atribución/Reconocimiento-NoComercial-SinDerivados 4.0 Internacional